News

The company is carrying out the development of the RSV vaccine, as part of the TechnoVax program, using its proprietary VLP technology, which is a new way to

The results showed that the combination was generally well tolerated and produced evidence of clinical response. In the trial, 42% of immunotherapy-naïve patients who received ipilimumab with INCB24360

Around 10,000 patients with severe burns are hospitalized every year in South Korea and primarily are treated at about 10 burn centers. The easy-to-use, topically-applied pharmaceutical product ‘NexoBrid’

The company said that a six-month review period has been assigned for the Lemtrada sBLA and it expects FDA action on this in the fourth quarter. The sBLA

The Phase I trial is designed to assess the safety, tolerability and initial efficacy of altiratinib in these patients. In preclinical studies, altiratinib has been shown to exhibit

Nuvigil is a prescription medicine indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), shift work disorder (SWD) or narcolepsy. As

The Phase III trials of subcutaneous ofatumumab in relapsing-remitting multiple sclerosis (RRMS) are expected to start in 2015, following encouraging data from a Phase II trial reported in

Current Heel Inc. products will be available to USA distributors through August 2014, and to retailers and medical practitioners through December 2014. "We remain committed to serving the

"Sangamo’s powerful and precise ZFN-mediated genome editing technology allows us to modify a patient’s own stem cells and perform ‘autologous’ transplants, with the potential to replicate the functional